FDA wraps up Gilenya safety review; GSK nabs control of Cellzome for $98M;

 @FiercePharma: Italy's Rovati family finds partners with cash: Rottapharm sells 50% stake to private equity firms--BloombergStory | Follow @FiercePharma

> The FDA wrapped up its safety review of Novartis' ($NVS) multiple sclerosis drug Gilenya, concluding that certain patients with cardiovascular problems should avoid using it. Report

> GlaxoSmithKline ($GSK) paid $98 million to take full control of Cellzome, a biotech with expertise in inflammatory diseases. Article

> An official of the EU's top court said it should not adjust AstraZeneca's ($AZN) antitrust fine, levied in connection with patent strategies that held off generic competition for its Prilosec drug. Story

> GlaxoSmithKline defended its tax-payment record in the U.K. in the wake of a BBC report questioning a tax-saving setup in Luxembourg. Item

> A Takeda Pharmaceuticals dealmaker described her plans for scouting M&A prospects in the near term. News

> Hospira ($HSP) recalled one lot of injectable painkillers after discovering that vials may contain too much of the drug. More

> Scotland's cost-effectiveness watchdog recommended against Bristol-Myers Squibb's ($BMY) melanoma treatment Yervoy. Report

Biotech News

 @FierceBiotech: Mobile apps could rival pharma's crown jewels. More | Follow @FierceBiotech

 @RyanMFierce: Interesting case for why mobile health apps could compete with drugs and hurt pharma by @chasedaveAnalysis | Follow @RyanMFierce

 @JohnCFierce: New chief takes helm at Promedior (fibrosis) and steers a course for Boston. More | Follow @JohnCFierce

> First wave of AstraZeneca's CNS R&D group gets the ax. Story

> Newron soars on positive PhIII results, $26M pact for Parkinson's drug. Article

> Buzz: Big Pharma suitors line up for a look at Amylin's books. News

Medical Device News

 @FierceMedDev: Folks, the clock is ticking. Get your nominations in for the 15 fiercest device developers. Survey | Follow @FierceMedDev

> Sonitus Medical lands $25 million Series D round for hearing device. More

> After quiet Q4, device recalls surge in 2012. News

> Boston Sci, Abbott gain European sign-off for stent products & services. Story

Pharma Manufacturing News

> U.K. pharmacy group wants drug exports stopped. Story

> Merck KGaA says cuts will save $385 million. News

> Pakistan's ephedrine scandal takes on international intrigue. Article

Biotech Research News

> Scientist uses stem cells to rebuild bone. News

> How do you make a deaf mouse hear? Emory University tries gene therapy. More

> Compounds may combat cancers by reversing p53 mutation. Article

And Finally... How can genetic sequencing be incorporated in day-to-day patient care? Story